Dissemin is shutting down on January 1st, 2025

Published in

Springer, Cancer Causes and Control, 5(27), p. 679-693, 2016

DOI: 10.1007/s10552-016-0741-6

Links

Tools

Export citation

Search in Google Scholar

Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry

Journal article published in 2016 by Z. (Zhiguo) Zhao, W. (Wanqing) Wen, K. (Kyriaki) Michailidou, Q. (Qing) Wang, B. (Bin) Zhang, Manjeet K. (Manjeet) Bolla, J. (Jirong) Long, X.-O. (Xiao-Ou) Shu, Marjanka K. (Marjanka) Schmidt ORCID, Roger L. (Roger) Milne, M. (Montserrat) García-Closas, S. (Stephen) Lindstrom, K. (Kamila) Czene, T. (Thilo) Dörk, M. (Martine) Dumont and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Purpose: Type 2 diabetes (T2D) has been reported to be associated with an elevated risk of breast cancer. It is unclear, however, whether this association is due to shared genetic factors. Methods: We constructed a genetic risk score (GRS) using risk variants from 33 known independent T2D susceptibility loci and evaluated its relation to breast cancer risk using the data from two consortia, including 62,328 breast cancer patients and 83,817 controls of European ancestry. Unconditional logistic regression models were used to derive adjusted odds ratios (ORs) and 95 % confidence intervals (CIs) to measure the association of breast cancer risk with T2D GRS or T2D-associated genetic risk variants. Meta-analyses were conducted to obtain summary ORs across all studies. Results: The T2D GRS was not found to be associated with breast cancer risk, overall, by menopausal status, or for estrogen receptor positive or negative breast cancer. Three T2D associated risk variants were individually associated with breast cancer risk after adjustment for multiple comparisons using the Bonferroni method (at p